Molecular MRI Aims at Component of Multiple Cancers

June 16, 2015

The prostate-specific membrane antigen (PSMA) biomarker is the bullseye for three newmagnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types. 

The agents were discussed in research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Read the full story.